Arbutus Biopharma Corporation(ABUS)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ABUS Arbutus Biopharma Corporation

未开盘 11-18 16:00:00 EST

3.52

-0.12

-3.30%

盘后3.53

+0.01+0.28%

18:40 EST

最高3.68	最低3.49	成交量106.38万
今开3.64	昨收3.64	日振幅5.22%
总市值6.67亿	流通市值4.79亿	总股本1.89亿
成交额378.40万	换手率0.78%	流通股本1.36亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"ABUS","market":"US","secType":"STK","nameCN":"Arbutus Biopharma Corporation","latestPrice":3.52,"timestamp":1731963600000,"preClose":3.64,"halted":0,"volume":1063750,"hourTrading":{"tag":"盘后","latestPrice":3.53,"preClose":3.52,"latestTime":"18:40 EST","volume":14135,"amount":49757.34,"timestamp":1731973241362},"delay":0,"floatShares":136219186,"shares":189491685,"eps":-0.426293,"marketStatus":"未开盘","marketStatusCode":0,"change":-0.12,"latestTime":"11-18 16:00:00 EST","open":3.64,"high":3.68,"low":3.49,"amount":3784048.30275,"amplitude":0.052198,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.426293,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1732006800000},"adr":0,"listingDate":1184904000000,"adjPreClose":3.64,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":3.63,"preClose":3.64,"latestTime":"09:25 EST","volume":1359,"amount":4947.897483,"timestamp":1731939900123},"postHourTrading":{"tag":"盘后","latestPrice":3.53,"preClose":3.52,"latestTime":"18:40 EST","volume":14135,"amount":49757.34,"timestamp":1731973241362},"volumeRatio":1.024187,"impliedVol":0.2936,"impliedVolPercentile":0.1195},"requestUrl":"/m/hq/s/ABUS","defaultTab":"news","newsList":[{"id":"2483306970","title":"Arbutus Biopharma Corporation盘中异动 早盘快速下跌5.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483306970","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483306970?lang=zh_cn&edition=full","pubTime":"2024-11-16 00:01","pubTimestamp":1731686468,"startTime":"0","endTime":"0","summary":"北京时间2024年11月16日00时01分，Arbutus Biopharma Corporation股票出现异动，股价急速下挫5.23%。截至发稿，该股报3.44美元/股，成交量38.2825万股，换手率0.20%，振幅6.20%。Arbutus Biopharma Corporation股票所在的生物技术行业中，整体跌幅为3.47%。Arbutus Biopharma Corporation公司简介：Arbutus Biopharma Corp 是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241116000110abc513dd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241116000110abc513dd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ABUS"],"gpt_icon":0},{"id":"2483837423","title":"Arbutus Biopharma Corporation2024财年第三财季实现净利润-19.72百万美元，同比增加1.89%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483837423","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483837423?lang=zh_cn&edition=full","pubTime":"2024-11-15 00:01","pubTimestamp":1731600063,"startTime":"0","endTime":"0","summary":"11月15日，Arbutus Biopharma Corporation公布财报，公告显示公司2024财年第三财季净利润为-19.72百万美元，同比增加1.89%；其中营业收入为1.34百万美元，同比减少71.24%，每股基本收益为-0.10美元。从资产负债表来看，Arbutus Biopharma Corporation总负债33.55百万美元，其中短期债务468000.00美元，资产负债比为0.05，流动比率为0.08。机构评级：截至2024年11月15日，当前有5家机构对Arbutus Biopharma Corporation目标价做出预测，其中目标均价为5.10美元，其中最低目标价为4.00美元，最高目标价为7.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241115000121a238002f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241115000121a238002f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ABUS"],"gpt_icon":0},{"id":"2481135474","title":"Arbutus Biopharma Corporation盘中异动 股价大跌5.10%报3.72美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2481135474","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481135474?lang=zh_cn&edition=full","pubTime":"2024-11-08 00:59","pubTimestamp":1730998779,"startTime":"0","endTime":"0","summary":"北京时间2024年11月08日00时59分，Arbutus Biopharma Corporation股票出现波动，股价快速跳水5.10%。截至发稿，该股报3.72美元/股，成交量36.1723万股，换手率0.19%，振幅4.85%。Arbutus Biopharma Corporation股票所在的生物技术行业中，整体涨幅为0.48%。其相关个股中，Tevogen Bio Holdings Inc C/Wts 14/02/2029 、Cingulate Inc C/Wts 10/12/2026 、Celularity Inc.涨幅较大，Ensysce Biosciences, Inc.、Elevai Labs, Inc.、Cyclacel Pharmaceuticals, Inc.较为活跃，换手率分别为864.99%、385.85%、105.42%，振幅较大的相关个股有Celularity Inc.、180 Life Sciences Corp C/Wts 07/11/2025、Ensysce Biosciences, Inc.，振幅分别为84.83%、68.89%、57.79%。Arbutus Biopharma Corporation公司简介：Arbutus Biopharma Corp 是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241108005940a2213c52&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241108005940a2213c52&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ABUS"],"gpt_icon":0},{"id":"2481986081","title":"Arbutus Biopharma Corporation盘中异动 急速跳水5.15%报3.76美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2481986081","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481986081?lang=zh_cn&edition=full","pubTime":"2024-11-06 22:32","pubTimestamp":1730903555,"startTime":"0","endTime":"0","summary":"北京时间2024年11月06日22时32分，Arbutus Biopharma Corporation股票出现异动，股价快速下挫5.15%。截至发稿，该股报3.76美元/股，成交量5.0993万股，换手率0.03%，振幅3.79%。Arbutus Biopharma Corporation股票所在的生物技术行业中，整体涨幅为0.49%。其相关个股中，Sonnet Biotherapeutics Holdings, Inc.、Sab Biotherapeutics Inc C/Wts 22/10/2026 、Psyence Biomedical Ltd C/Wts 25/01/2029涨幅较大，Sonnet Biotherapeutics Holdings, Inc.、Elevai Labs, Inc.、Zyversa Therapeutics, Inc.较为活跃，换手率分别为1070.77%、100.21%、52.15%，振幅较大的相关个股有Fate Therapeutics, Inc.、Nurix Therapeutics, Inc.、Inmed Pharmaceuticals Inc.，振幅分别为107.84%、106.06%、106.04%。Arbutus Biopharma Corporation公司简介：Arbutus Biopharma Corp 是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241106223235971a4bf7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241106223235971a4bf7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ABUS"],"gpt_icon":0},{"id":"2480580294","title":"Arbutus Biopharma Corp    预计每股亏损 9 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2480580294","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480580294?lang=zh_cn&edition=full","pubTime":"2024-11-04 23:45","pubTimestamp":1730735153,"startTime":"0","endTime":"0","summary":"   * Arbutus Biopharma公司   预计在11月6日公布截至0001年1月1日的业绩报告时将出现季度收入下降。* 根据LSEG的数据，5位分析师的平均预期显示，这家总部位于宾夕法尼亚州沃明斯特的公司的营收将从去年同期的466万美元降至186万美元，降幅为60.1%。* LSEG 分析师对 Arbutus Biopharma Corp 的平均预期是每股亏损 9 美分。* 华尔街对 Arbutus Biopharma Corp 的 12 个月目标价中位数为 5.00 美元，高于其上一次收盘价 3.96 美元。11月4日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Arbutus Biopharma Corp    预计每股亏损 9 美分 - 财报前瞻","news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABUS"],"gpt_icon":0},{"id":"2475263012","title":"Arbutus Biopharma Corporation盘中异动 股价大涨5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2475263012","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2475263012?lang=zh_cn&edition=full","pubTime":"2024-10-16 00:36","pubTimestamp":1729010179,"startTime":"0","endTime":"0","summary":"北京时间2024年10月16日00时36分，Arbutus Biopharma Corporation股票出现波动，股价急速上涨5.05%。截至发稿，该股报4.06美元/股，成交量31.6833万股，换手率0.17%，振幅4.15%。Arbutus Biopharma Corporation股票所在的生物技术行业中，整体跌幅为0.64%。Arbutus Biopharma Corporation公司简介：Arbutus Biopharma Corp 是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241016003619a1e0dc87&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241016003619a1e0dc87&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ABUS"],"gpt_icon":0},{"id":"2465954512","title":"美国研究综述-可口可乐、KB Home、纽马克集团","url":"https://stock-news.laohu8.com/highlight/detail?id=2465954512","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2465954512?lang=zh_cn&edition=full","pubTime":"2024-09-05 20:52","pubTimestamp":1725540777,"startTime":"0","endTime":"0","summary":"    路透9月5日 - 华尔街证券分析师周四调整了对几家美国上市公司的评级和目标价，其中包括可口可乐、KB Home 和 Newmark Group。* 可口可乐公司   ：CFRA将其评级从 \"买入 \"下调至 \"持有 * KB Home   ：加拿大皇家银行将其评级从 \"行业表现 \"下调至 \"表现不佳\"。* 纽马克集团  ：KBW将其评级从 \"市场表现 \"上调至 \"跑赢大盘\"。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABUS","GNK","CMA","LZ","PLAY","BK4086","LU1951198990.SGD","CPT","CACI","JILL","CASY","KREF","LU1868837136.USD","LU1868836591.USD","MRCY","LU1732800096.USD","CE","ATYR","CNM","BK4543","LU1093756168.USD","KBH","AVAH","X","KO","BBCP","JWN","CHPT","LH","NMRK","CCEC","AVAV","KB","HUM","ODFL","ARCB","OS","LOAR","CARR","BMRN","CIEN","DKS","LU2286300806.USD","LU1868836914.USD","BASE"],"gpt_icon":1},{"id":"2459901426","title":"Arbutus Biopharma Corporation盘中异动 早盘股价大涨5.11%报3.81美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2459901426","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459901426?lang=zh_cn&edition=full","pubTime":"2024-08-13 21:44","pubTimestamp":1723556694,"startTime":"0","endTime":"0","summary":"北京时间2024年08月13日21时44分，Arbutus Biopharma Corporation股票出现波动，股价快速拉升5.11%。截至发稿，该股报3.81美元/股，成交量15.1264万股，换手率0.08%，振幅4.40%。Arbutus Biopharma Corporation股票所在的生物技术行业中，整体涨幅为0.70%。Arbutus Biopharma Corporation公司简介：Arbutus Biopharma Corp 是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240813214455aefe9f42&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240813214455aefe9f42&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ABUS","BK4139"],"gpt_icon":0},{"id":"2458126516","title":"Arbutus Biopharma Corporation2024财年第二财季实现净利润-19.80百万美元，同比减少15.86%","url":"https://stock-news.laohu8.com/highlight/detail?id=2458126516","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458126516?lang=zh_cn&edition=full","pubTime":"2024-08-10 00:18","pubTimestamp":1723220297,"startTime":"0","endTime":"0","summary":"8月10日，Arbutus Biopharma Corporation公布财报，公告显示公司2024财年第二财季净利润为-19.80百万美元，同比减少15.86%；其中营业收入为1.73百万美元，同比减少62.80%，每股基本收益为-0.11美元。从资产负债表来看，Arbutus Biopharma Corporation总负债37.59百万美元，其中短期债务453000.00美元，资产负债比为0.05，流动比率为0.07。机构评级：截至2024年8月10日，当前有5家机构对Arbutus Biopharma Corporation目标价做出预测，其中目标均价为4.60美元，其中最低目标价为4.00美元，最高目标价为5.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408100018209f1e10c1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408100018209f1e10c1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ABUS"],"gpt_icon":0},{"id":"1198915676","title":"异动解读 | Arbutus Biopharma公布季度亏损扩大 股价盘中大跌9.47%","url":"https://stock-news.laohu8.com/highlight/detail?id=1198915676","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1198915676?lang=zh_cn&edition=full","pubTime":"2024-08-01 21:51","pubTimestamp":1722520308,"startTime":"0","endTime":"0","summary":"Arbutus Biopharma Corporation(ABUS)今日盘中股价大跌9.47%,引发市场关注。公司此前公布的最新季度财报显示,业绩不佳或是导致股价下跌的主要原因。\n\n财报数据显示,Arbutus Biopharma本季度调整后每股亏损11美分,低于分析师预期的10美分亏损。营收173万美元,同比下降62.9%,也低于预期。公司本季度亏损1980万美元。\n\n尽管如此,公司股价在本季度和今年迄今的表现依然强劲,分别上涨22%和50.8%。分析师对该股的评级为\"买入\",看好公司的长期前景。但财报数据的疲软表现可能加剧了投资者的担忧,导致股价在盘中出现大幅下跌。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABUS"],"gpt_icon":0},{"id":"2456438976","title":"Arbutus 生物制药公司公布截至 6 月的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2456438976","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2456438976?lang=zh_cn&edition=full","pubTime":"2024-08-01 21:34","pubTimestamp":1722519279,"startTime":"0","endTime":"0","summary":"   * Arbutus Biopharma Corp   报告了截至6月底的季度调整后每股亏损11美分，低于去年同期的每股-10美分。五位分析师对该季度的平均预期是每股亏损 10 美分。华尔街预期为每股-11美分至-8美分。* Arbutus Biopharma Corp公布的本季度每股收益为亏损11美分。* 该公司报告的季度亏损额为 1,980 万美元。* Arbutus Biopharma Corp的股价本季度上涨了22.0%，今年迄今为止上涨了50.8%。* 生物技术和医学研究同行的平均一致建议也是 \"买入\"。华尔街对 Arbutus Biopharma Corp 的 12 个月目标价中位数为 4.00 美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ABUS"],"gpt_icon":0},{"id":"2456433960","title":"Arbutus Biopharma Corporation盘中异动 股价大跌5.57%报3.56美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2456433960","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2456433960?lang=zh_cn&edition=full","pubTime":"2024-08-01 21:31","pubTimestamp":1722519078,"startTime":"0","endTime":"0","summary":"北京时间2024年08月01日21时31分，Arbutus Biopharma Corporation股票出现波动，股价急速跳水5.57%。截至发稿，该股报3.56美元/股，成交量6.9902万股，换手率0.04%，振幅1.06%。Arbutus Biopharma Corporation股票所在的生物技术行业中，整体跌幅为0.46%。其相关个股中，Immuneering Corporation、Entera Bio Ltd.、Biomea Fusion, Inc.涨幅较大，Immuneering Corporation、Cns Pharmaceuticals, Inc.、Neurosense Therapeutics Ltd.较为活跃，换手率分别为45.17%、37.36%、13.65%，振幅较大的相关个股有Biomea Fusion, Inc.、Reviva Pharmaceuticals Holdings, Inc.、Neurosense Therapeutics Ltd.，振幅分别为11.58%、11.54%、10.71%。Arbutus Biopharma Corporation公司简介：Arbutus Biopharma Corp 是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024080121311896822af9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024080121311896822af9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ABUS"],"gpt_icon":0},{"id":"2455085963","title":"Arbutus Biopharma Corp    预计每股亏损 10 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2455085963","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455085963?lang=zh_cn&edition=full","pubTime":"2024-07-31 01:16","pubTimestamp":1722359769,"startTime":"0","endTime":"0","summary":"   * Arbutus Biopharma Corp    将于8月1日公布截至2024年6月30日的财报，预计该公司的季度收入将出现下降。* 根据LSEG的数据，5位分析师的平均预期显示，这家总部位于宾夕法尼亚州沃明斯特的公司的营收将从去年同期的465万美元下降62.3%，至175.5万美元。* LSEG 分析师对 Arbutus Biopharma Corp 的平均预期是每股亏损 10 美分。* 华尔街对 Arbutus Biopharma Corp 的 12 个月目标价中位数为 4.00 美元，高于上一交易日的收盘价 3.78 美元。7月30日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABUS"],"gpt_icon":0},{"id":"2452664211","title":"Arbutus Biopharma Corporation盘中异动 早盘股价大跌5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2452664211","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2452664211?lang=zh_cn&edition=full","pubTime":"2024-07-17 23:11","pubTimestamp":1721229067,"startTime":"0","endTime":"0","summary":"北京时间2024年07月17日23时11分，Arbutus Biopharma Corporation股票出现波动，股价快速下跌5.03%。截至发稿，该股报3.69美元/股，成交量30.0829万股，换手率0.16%，振幅3.61%。Arbutus Biopharma Corporation股票所在的生物技术行业中，整体跌幅为2.56%。其相关个股中，Aptevo Therapeutics Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Moolec Science Sa C/Wts 涨幅较大，Aptevo Therapeutics Inc.、Aditxt, Inc.、Longeveron Inc.较为活跃，换手率分别为2893.86%、1299.57%、271.34%，振幅较大的相关个股有Aptevo Therapeutics Inc.、Aditxt, Inc.、Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 ，振幅分别为76.39%、46.25%、43.75%。Arbutus Biopharma Corporation公司简介：Arbutus Biopharma Corp 是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407172311079681db31&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407172311079681db31&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ABUS","BK4139"],"gpt_icon":0},{"id":"2451672872","title":"Arbutus Biopharma Corporation盘中异动 大幅上涨5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2451672872","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2451672872?lang=zh_cn&edition=full","pubTime":"2024-07-16 03:08","pubTimestamp":1721070497,"startTime":"0","endTime":"0","summary":"北京时间2024年07月16日03时08分，Arbutus Biopharma Corporation股票出现波动，股价大幅上涨5.01%。截至发稿，该股报3.77美元/股，成交量88.1699万股，换手率0.47%，振幅5.57%。Arbutus Biopharma Corporation股票所在的生物技术行业中，整体涨幅为0.64%。其相关个股中，Protagenic Therapeutics Inc C/Wts 29/04/2026 、Revolution Medicines Inc C/Wts 17/12/2026 、Aeon Biopharma, Inc.涨幅较大，Scinai Immunotherapeutics Ltd、Qualigen Therapeutics, Inc.、Aeon Biopharma, Inc.较为活跃，换手率分别为3418.84%、180.07%、139.65%，振幅较大的相关个股有Aeon Biopharma, Inc.、Revolution Medicines Inc C/Wts 17/12/2026 、Scinai Immunotherapeutics Ltd，振幅分别为150.36%、110.42%、91.37%。Arbutus Biopharma Corporation公司简介：Arbutus Biopharma Corp 是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240716030817aef9c766&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240716030817aef9c766&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ABUS"],"gpt_icon":0},{"id":"2449064377","title":"Arbutus Biopharma Corporation盘中异动 大幅拉升5.45%","url":"https://stock-news.laohu8.com/highlight/detail?id=2449064377","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2449064377?lang=zh_cn&edition=full","pubTime":"2024-07-08 22:03","pubTimestamp":1720447434,"startTime":"0","endTime":"0","summary":"北京时间2024年07月08日22时03分，Arbutus Biopharma Corporation股票出现波动，股价快速上涨5.45%。截至发稿，该股报3.29美元/股，成交量14.9571万股，换手率0.08%，振幅4.33%。Arbutus Biopharma Corporation股票所在的生物技术行业中，整体涨幅为0.67%。其相关个股中，Morphic Holding, Inc.、Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Virpax Pharmaceuticals, Inc.涨幅较大，Virpax Pharmaceuticals, Inc.、Cero Therapeutics Holdings, Inc.、Kineta, Inc.较为活跃，换手率分别为830.14%、162.26%、133.91%，振幅较大的相关个股有Virpax Pharmaceuticals, Inc.、Cero Therapeutics Holdings, Inc.、180 Life Sciences Corp C/Wts 07/11/2025，振幅分别为65.74%、36.60%、34.48%。Arbutus Biopharma Corporation公司简介：Arbutus Biopharma Corp 是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407082203559681aaa2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407082203559681aaa2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ABUS"],"gpt_icon":0},{"id":"2441509727","title":"Arbutus Biopharma Corporation盘中异动 大幅下挫5.09%报3.17美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2441509727","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2441509727?lang=zh_cn&edition=full","pubTime":"2024-06-08 02:52","pubTimestamp":1717786377,"startTime":"0","endTime":"0","summary":"北京时间2024年06月08日02时52分，Arbutus Biopharma Corporation股票出现异动，股价大幅跳水5.09%。Arbutus Biopharma Corporation股票所在的生物技术行业中，整体涨幅为0.01%。Arbutus Biopharma Corporation公司简介：Arbutus Biopharma Corp 是一家生物制药公司。消息层面，截至02时52分，《JMP Securities维持Arbutus Biopharma买入评级，维持目标价4美元》资讯为影响Arbutus Biopharma Corporation的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240608025258941ed5b9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240608025258941ed5b9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ABUS"],"gpt_icon":0},{"id":"2441060496","title":"HC Wainwright &amp; Co.：重申Arbutus Biopharma(ABUS.US)评级由买入调整至买入评级, 目标价由5.","url":"https://stock-news.laohu8.com/highlight/detail?id=2441060496","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2441060496?lang=zh_cn&edition=full","pubTime":"2024-06-07 23:30","pubTimestamp":1717774241,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4139","ABUS"],"gpt_icon":0},{"id":"2441792345","title":"HC Wainwright &amp; Co.：重申Arbutus Biopharma(ABUS.US)评级，由买入调整至买入评级, 目标价由5.","url":"https://stock-news.laohu8.com/highlight/detail?id=2441792345","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2441792345?lang=zh_cn&edition=full","pubTime":"2024-06-06 18:36","pubTimestamp":1717670180,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4139","ABUS"],"gpt_icon":0},{"id":"2441771272","title":"Arbutus Biopharma Corporation盘中异动 早盘股价大涨5.09%报3.51美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2441771272","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2441771272?lang=zh_cn&edition=full","pubTime":"2024-06-05 22:30","pubTimestamp":1717597830,"startTime":"0","endTime":"0","summary":"北京时间2024年06月05日22时30分，Arbutus Biopharma Corporation股票出现异动，股价急速上涨5.09%。截至发稿，该股报3.51美元/股，成交量32.6734万股，换手率0.17%，振幅4.19%。Arbutus Biopharma Corporation股票所在的生物技术行业中，整体涨幅为0.72%。其相关个股中，Kineta, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、诺瓦瓦克斯医药涨幅较大，Adial Pharmaceuticals, Inc、Cns Pharmaceuticals, Inc.、Mustang Bio, Inc.较为活跃，换手率分别为47.42%、43.91%、10.03%，振幅较大的相关个股有Biocardia Inc C/Wts 06/08/2024、Kineta, Inc.、Silo Pharma, Inc.，振幅分别为41.80%、36.42%、23.56%。Arbutus Biopharma Corporation公司简介：Arbutus Biopharma Corp 是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024060522303196812336&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024060522303196812336&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ABUS","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.arbutusbio.com","stockEarnings":[{"period":"1week","weight":-0.0563},{"period":"1month","weight":-0.1518},{"period":"3month","weight":-0.0809},{"period":"6month","weight":0.0323},{"period":"1year","weight":0.8925},{"period":"ytd","weight":0.408}],"compareEarnings":[{"period":"1week","weight":-0.0177},{"period":"1month","weight":0.0061},{"period":"3month","weight":0.0527},{"period":"6month","weight":0.1101},{"period":"1year","weight":0.3047},{"period":"ytd","weight":0.2374}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Arbutus Biopharma Corporation于2005年10月6日在不列颠哥伦比亚省注册成立。该公司是一家临床阶段的生物制药公司，利用其广泛的病毒学专业知识来识别和开发具有独特作用机制的新疗法，这些疗法可以潜在地结合起来，为慢性乙型肝炎病毒（HBV）感染患者提供功能性治愈。公司内部开发的专有化合物管线包括一种RNA治疗药物imdusiran（AB-729）和一种口服PD-L1抑制剂AB-101。Imdusiran已经产生了有意义的临床数据，证明了对表面抗原减少和HBV特异性免疫反应的重新唤醒的影响。","yearOnYearQuotes":[{"month":1,"riseRate":0.444444,"avgChangeRate":-0.030395},{"month":2,"riseRate":0.777778,"avgChangeRate":0.069865},{"month":3,"riseRate":0.333333,"avgChangeRate":-0.063185},{"month":4,"riseRate":0.666667,"avgChangeRate":-0.000549},{"month":5,"riseRate":0.444444,"avgChangeRate":0.054581},{"month":6,"riseRate":0.555556,"avgChangeRate":0.017563},{"month":7,"riseRate":0.444444,"avgChangeRate":0.167453},{"month":8,"riseRate":0.333333,"avgChangeRate":-0.033296},{"month":9,"riseRate":0.5,"avgChangeRate":0.056874},{"month":10,"riseRate":0.1,"avgChangeRate":-0.092441},{"month":11,"riseRate":0.6,"avgChangeRate":0.050057},{"month":12,"riseRate":0.333333,"avgChangeRate":0.041025}],"exchange":"NASDAQ","name":"Arbutus Biopharma Corporation","nameEN":"Arbutus Biopharma"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Arbutus Biopharma Corporation(ABUS)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Arbutus Biopharma Corporation(ABUS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Arbutus Biopharma Corporation,ABUS,Arbutus Biopharma Corporation股票,Arbutus Biopharma Corporation股票老虎,Arbutus Biopharma Corporation股票老虎国际,Arbutus Biopharma Corporation行情,Arbutus Biopharma Corporation股票行情,Arbutus Biopharma Corporation股价,Arbutus Biopharma Corporation股市,Arbutus Biopharma Corporation股票价格,Arbutus Biopharma Corporation股票交易,Arbutus Biopharma Corporation股票购买,Arbutus Biopharma Corporation股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Arbutus Biopharma Corporation(ABUS)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Arbutus Biopharma Corporation(ABUS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}